These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 21261747)

  • 1. Instrumental analysis of the pattern of improvement and that of recurrence of melasma in Thai females treated with Kligman-Willis triple combination therapy: confirmation by using its two different formulae.
    Pratchyapruit W; Vashrangsi N; Sindhavananda J; Tagami H
    Skin Res Technol; 2011 May; 17(2):226-33. PubMed ID: 21261747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intermittent therapy for melasma in Asian patients with combined topical agents (retinoic acid, hydroquinone and hydrocortisone): clinical and histological studies.
    Kang WH; Chun SC; Lee S
    J Dermatol; 1998 Sep; 25(9):587-96. PubMed ID: 9798345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treating epidermal melasma with a 4% hydroquinone skin care system plus tretinoin cream 0.025%.
    Grimes P; Watson J
    Cutis; 2013 Jan; 91(1):47-54. PubMed ID: 23461059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationale for the use of topical corticosteroids in melasma.
    Menter A
    J Drugs Dermatol; 2004; 3(2):169-74. PubMed ID: 15098972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-fluence Q-switched neodymium-doped yttrium aluminum garnet laser for melasma with pre- or post-treatment triple combination cream.
    Draelos Z
    Dermatol Surg; 2011 Jan; 37(1):126-7. PubMed ID: 21214668
    [No Abstract]   [Full Text] [Related]  

  • 6. Raman spectroscopy analysis of the skin of patients with melasma before standard treatment with topical corticosteroids, retinoic acid, and hydroquinone mixture.
    Moncada B; Castillo-Martínez C; Arenas E; León-Bejarano F; Ramírez-Elías MG; González FJ
    Skin Res Technol; 2016 May; 22(2):170-3. PubMed ID: 26179661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous therapy followed by a maintenance therapy regimen with a triple combination cream for melasma.
    Grimes PE; Bhawan J; Guevara IL; Colón LE; Johnson LA; Gottschalk RW; Pandya AG
    J Am Acad Dermatol; 2010 Jun; 62(6):962-7. PubMed ID: 20398959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined use of two formulations containing diacetyl boldine, TGF-β1 biomimetic oligopeptide-68 with other hypopigmenting/exfoliating agents and sunscreen provides effective and convenient treatment for facial melasma. Either is equal to or is better than 4% hydroquinone on normal skin.
    Pratchyapurit WO
    J Cosmet Dermatol; 2016 Jun; 15(2):131-44. PubMed ID: 26833454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of 4% hydroquinone combined with 10% glycolic acid, antioxidants, and sunscreen in the treatment of melasma.
    Guevara IL; Pandya AG
    Int J Dermatol; 2003 Dec; 42(12):966-72. PubMed ID: 14636195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential treatment with triple combination cream and intense pulsed light is more efficacious than sequential treatment with an inactive (control) cream and intense pulsed light in patients with moderate to severe melasma.
    Goldman MP; Gold MH; Palm MD; Colón LE; Preston N; Johnson LA; Gottschalk RW
    Dermatol Surg; 2011 Feb; 37(2):224-33. PubMed ID: 21269349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral Tranexemic Acid With Triple Combination Cream (Flucinolone+Hydroquinone+Tretinoin) Versus Triple Combination Cream Alone In Treatment Of Melasma.
    Basit A; Rahman A; Uddin R
    J Ayub Med Coll Abbottabad; 2021; 33(2):293-298. PubMed ID: 34137548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melasma--updated treatments.
    Situm M; Kolić M; Bolanca Z; Ljubicić I; Misanović B
    Coll Antropol; 2011 Sep; 35 Suppl 2():315-8. PubMed ID: 22220462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of hydroquinone (2%) versus tretinoin (0.025%) as adjunct topical agents for chemical peeling in patients of melasma.
    Nanda S; Grover C; Reddy BS
    Dermatol Surg; 2004 Mar; 30(3):385-8; discussion 389. PubMed ID: 15008866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-fluence Q-switched neodymium-doped yttrium aluminum garnet laser for melasma with pre- or post-treatment triple combination cream.
    Jeong SY; Shin JB; Yeo UC; Kim WS; Kim IH
    Dermatol Surg; 2010 Jun; 36(6):909-18. PubMed ID: 20384749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective randomized controlled trial comparing treatment efficacy and tolerance of picosecond alexandrite laser with a diffractive lens array and triple combination cream in female asian patients with melasma.
    Wang YJ; Lin ET; Chen YT; Chiu PC; Lin BS; Chiang HM; Huang YH; Wang KY; Lin HY; Chang TM; Chang CC
    J Eur Acad Dermatol Venereol; 2020 Mar; 34(3):624-632. PubMed ID: 31494973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of retinoic acid in the treatment of melasma.
    Pathak MA; Fitzpatrick TB; Kraus EW
    J Am Acad Dermatol; 1986 Oct; 15(4 Pt 2):894-9. PubMed ID: 3534025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized controlled trial of the efficacy and safety of a fixed triple combination (fluocinolone acetonide 0.01%, hydroquinone 4%, tretinoin 0.05%) compared with hydroquinone 4% cream in Asian patients with moderate to severe melasma.
    Chan R; Park KC; Lee MH; Lee ES; Chang SE; Leow YH; Tay YK; Legarda-Montinola F; Tsai RY; Tsai TH; Shek S; Kerrouche N; Thomas G; Verallo-Rowell V
    Br J Dermatol; 2008 Sep; 159(3):697-703. PubMed ID: 18616780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigator-Blinded, Single-Center Study to Evaluate the Efficacy and Tolerability of a 4% Hydroquinone Skin Care System Plus 0.02% Tretinoin Cream in Mild-to-Moderate Melasma and Photodamage.
    Rendon M; Dryer L
    J Drugs Dermatol; 2016 Apr; 15(4):466-75. PubMed ID: 27050702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Objective assessment of erythema and pigmentation of melasma lesions and surrounding areas in long-term management regimens with triple combination.
    Hexsel D; Soirefmann M; Fernandes JD; Siega C
    J Drugs Dermatol; 2014 Apr; 13(4):444-8. PubMed ID: 24719064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preventing melasma recurrence: prescribing a maintenance regimen with an effective triple combination cream based on long-standing clinical severity.
    Arellano I; Cestari T; Ocampo-Candiani J; Azulay-Abulafia L; Bezerra Trindade Neto P; Hexsel D; Machado-Pinto J; Muñoz H; Rivitti-Machado MC; Sittart JA; Trindade de Almeida AR; Rego V; Paliargues F; Marques-Hassun K
    J Eur Acad Dermatol Venereol; 2012 May; 26(5):611-8. PubMed ID: 21623930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.